Sandu Pharmaceuticals Limited’s Board of Directors convened on August 11, 2026, approving the unaudited standalone financial results for the quarter ended June 30, 2026. The Board also declared a record date of September 4, 2026, for determining the eligibility of members entitled to a proposed dividend for the financial year ended March 31, 2026. Additionally, the company announced the 41st Annual General Meeting (AGM) for September 11, 2026, and recommended the appointment of M/s. Dave & Dave as statutory auditors.
Board Meeting Highlights
Sandu Pharmaceuticals Limited held a Board of Directors meeting on Tuesday, August 11, 2026, to discuss and approve key business matters. The Board reviewed and approved the unaudited standalone financial results for the first quarter ended June 30, 2026, along with the Limited Review Report issued by the Statutory Auditors. These results were subsequently taken on record by the Board.
Annual Report and AGM Details
The Directors’ Report, Management Discussion and Analysis Report, Corporate Governance Report, and Secretarial Audit Report for the financial year ended March 31, 2026, were also approved. These reports are part of the Annual Report for the financial year 2025-26 and will be circulated to members in connection with the upcoming Annual General Meeting (AGM). The 41st AGM has been scheduled for Friday, September 11, 2026, at 4:30 PM IST, to be conducted via Video Conferencing/Other Audio-Visual Means.
Record Date and Dividend Announcement
In preparation for the ensuing AGM, the company approved the closure of its Register of Members and Share Transfer Books from Friday, September 4, 2026, to Friday, September 11, 2026, inclusive. The record date for determining the eligibility of members to receive the proposed dividend for the financial year ended March 31, 2026, has been set as Friday, September 4, 2026.
Auditor Appointment and Related Party Transactions
The Board also recommended the appointment of M/s. Dave & Dave, Chartered Accountants, as the Statutory Auditors for a first term of five consecutive years, commencing from the conclusion of the upcoming AGM until the AGM in 2031, subject to member approval. Furthermore, the Board recommended seeking member approval for the continuation of Material Related Party Transactions with M/s. Sandu Brothers Private Limited at the AGM.
Financial Review
The company’s unaudited standalone statement of profit and loss for the quarter ended June 30, 2026, shows a profit before tax of ₹36.05 lakhs and a profit for the period of ₹22.82 lakhs. Comprehensive income for the period, net of tax, was ₹38.35 lakhs. Earnings per equity share were ₹0.37 (Basic and Diluted) for the quarter.
Source: BSE
